These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 18433113

  • 21. Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties.
    Lacivita E, Di Pilato P, Stama ML, Colabufo NA, Berardi F, Perrone R, De Filippis B, Laviola G, Adriani W, Niso M, Leopoldo M.
    Bioorg Med Chem Lett; 2013 Nov 15; 23(22):6083-6. PubMed ID: 24100077
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA, Salerno L, Modica MN, Pittalà V, Romeo G, Amato ME, Nowak M, Bojarski AJ, Mereghetti I, Cagnotto A, Mennini T.
    J Med Chem; 2008 Aug 14; 51(15):4529-38. PubMed ID: 18598015
    [Abstract] [Full Text] [Related]

  • 24. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S, Sallés J.
    Neuropharmacology; 2009 Feb 14; 56(2):455-62. PubMed ID: 18951909
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics.
    Borthwick AD, Davies DE, Exall AM, Livermore DG, Sollis SL, Nerozzi F, Allen MJ, Perren M, Shabbir SS, Woollard PM, Wyatt PG.
    J Med Chem; 2005 Nov 03; 48(22):6956-69. PubMed ID: 16250654
    [Abstract] [Full Text] [Related]

  • 30. Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY.
    Yasuno F, Zoghbi SS, McCarron JA, Hong J, Ichise M, Brown AK, Gladding RL, Bacher JD, Pike VW, Innis RB.
    Synapse; 2006 Dec 01; 60(7):510-20. PubMed ID: 16952161
    [Abstract] [Full Text] [Related]

  • 31. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
    Ahmed M, Briggs MA, Bromidge SM, Buck T, Campbell L, Deeks NJ, Garner A, Gordon L, Hamprecht DW, Holland V, Johnson CN, Medhurst AD, Mitchell DJ, Moss SF, Powles J, Seal JT, Stean TO, Stemp G, Thompson M, Trail B, Upton N, Winborn K, Witty DR.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4867-71. PubMed ID: 16143522
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist.
    Leslie CP, Biagetti M, Bison S, Bromidge SM, Di Fabio R, Donati D, Falchi A, Garnier MJ, Jaxa-Chamiec A, Manchee G, Merlo G, Pizzi DA, Stasi LP, Tibasco J, Vong A, Ward SE, Zonzini L.
    J Med Chem; 2010 Dec 09; 53(23):8228-40. PubMed ID: 21053897
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives.
    Zhou D, Zhou P, Evrard DA, Meagher K, Webb M, Harrison BL, Huryn DM, Golembieski J, Hornby GA, Schechter LE, Smith DL, Andree TH, Mewshaw RE.
    Bioorg Med Chem; 2008 Jul 15; 16(14):6707-23. PubMed ID: 18571421
    [Abstract] [Full Text] [Related]

  • 38. Discovery of 3-aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists.
    Seong CM, Park WK, Park CM, Kong JY, Park NS.
    Bioorg Med Chem Lett; 2008 Jan 15; 18(2):738-43. PubMed ID: 18053713
    [Abstract] [Full Text] [Related]

  • 39. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
    Yoon J, Yoo EA, Kim JY, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY.
    Bioorg Med Chem; 2008 May 15; 16(10):5405-12. PubMed ID: 18456500
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.